Investor Stock List
Ranked #1,253 of 8,699 institutional investors

Soleus Capital Management, L.P.

Greenwich, CT

$2.64B
US stock portfolio at live prices · today −$22.6M (−0.85%)
Live prices, last trade 11:50 AM ET
Value at quarter end (Q3 2026)
$2.81B
Change from Q2 2026
−$89.0M (−3.07%)
Positions
88 · 24 new, 25 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$228M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
KRYS 13.5%PODD 9.01%TGTX 6.24%UTHR 5.45%CELC 3.46%
StockSharesValue, live% of portfoliovs Q2 2026
KRYS Krystal Biotech, Inc.1,139,700$356M13.5%Added +21%
PODD Insulet Corporation1,726,500$238M9.01%Added +65%
TGTX TG Therapeutics, Inc.2,556,168$165M6.24%Reduced −13%
UTHR United Therapeutics Corporation259,000$144M5.45%Added +15%
CELC Celcuity Inc.1,682,760$91.3M3.46%Reduced −1%
VCEL Vericel Corporation1,554,059$90.5M3.42%Added +7%
RIGL Rigel Pharmaceuticals, Inc.1,843,504$74.2M2.81%Unchanged
ERAS Erasca, Inc.5,112,000$71.8M2.72%Added +89%
INSP Inspire Medical Systems, Inc.1,206,828$67.0M2.54%Reduced −38%
ANIP ANI Pharmaceuticals, Inc.975,500$66.9M2.53%Added +12%
AXGN Axogen, Inc.1,081,000$60.3M2.28%Added +1,795%
PGNY Progyny, Inc.1,582,000$56.7M2.15%Reduced −1%
BBNX Beta Bionics, Inc.3,743,714$50.6M1.92%Reduced −15%
SLN Silence Therapeutics plc2,385,700$47.2M1.79%Added +279%
PBLS Parabilis Medicines, Inc.1,684,512$46.8M1.77%Added +15%
ARGX argenx SE49,350$46.4M1.75%Added +147%
GERN Geron Corporation46,768,659$42.4M1.61%Added +9%
TRVI Trevi Therapeutics, Inc.2,727,727$36.8M1.39%Added +131%
EOLS Evolus, Inc.5,090,000$35.4M1.34%Added +519%
NVCT Nuvectis Pharma, Inc.1,710,658$33.1M1.25%Added +71%
ZLAB Zai Lab Limited1,543,000$31.9M1.21%New
AVLN Avalyn Pharma Inc.1,019,000$28.7M1.09%Added +143%
KOD Kodiak Sciences Inc.286,966$28.2M1.07%New
NPCE NeuroPace, Inc.3,218,000$25.4M0.96%Added +11%
KIDS OrthoPediatrics Corp.710,198$22.8M0.86%Reduced −3%
INSM Insmed Incorporated147,000$21.3M0.81%Added +63%
FOCL EDAP TMS S.A.7,309,254$20.4M0.77%Unchanged
ETON Eton Pharmaceuticals, Inc.308,101$18.4M0.70%New
JBIO Jade Biosciences, Inc.1,170,928$17.9M0.68%Reduced −24%
TNGX Tango Therapeutics, Inc.802,297$17.8M0.67%Added +13%
PRAX Praxis Precision Medicines, Inc.56,515$17.3M0.66%Reduced −68%
LEGN Legend Biotech Corporation1,085,550$17.0M0.64%Reduced −10%
CNMD CONMED Corporation347,333$16.1M0.61%New
PRCT PROCEPT BioRobotics Corporation600,358$15.4M0.58%Reduced −40%
INBX Inhibrx Biosciences, Inc.210,000$15.0M0.57%New
IKT Inhibikase Therapeutics, Inc.11,225,000$14.6M0.55%Added +3%
AMRX Amneal Pharmaceuticals, Inc.658,000$13.9M0.53%New
PALI Palisade Bio, Inc.14,996,154$13.7M0.52%Added +15%
RCUS Arcus Biosciences, Inc.862,000$13.7M0.52%Reduced −26%
EWTX Edgewise Therapeutics, Inc.329,987$13.3M0.51%Reduced −27%
MBX MBX Biosciences, Inc.258,897$13.3M0.50%Reduced −50%
SEPN Septerna, Inc.330,000$12.9M0.49%Added +20%
SNY Sanofi275,000$12.8M0.48%New
NRIX Nurix Therapeutics, Inc.892,163$11.7M0.44%Reduced −39%
ANL Adlai Nortye Group Ltd.1,272,355$11.2M0.42%Added +214%
GRAL GRAIL, Inc.108,500$10.8M0.41%New
PRLD Prelude Therapeutics Incorporated3,378,378$10.8M0.41%Unchanged
ORGO Organogenesis Holdings Inc.11,300,951$9.0M0.34%Added +11%
TYRA Tyra Biosciences, Inc.445,025$8.9M0.34%New
CCCC C4 Therapeutics, Inc.3,357,981$8.3M0.32%Reduced −1%
LUNG Pulmonx Corporation3,088,323$8.2M0.31%Added +11%
XENE Xenon Pharmaceuticals Inc.205,000$7.7M0.29%Reduced −23%
BMRN BioMarin Pharmaceutical Inc.121,120$7.4M0.28%Reduced −68%
GKOS Glaukos Corporation25,552$6.1M0.23%New
TRAX First Tracks Biotherapeutics, Inc.140,500$5.9M0.22%New
RVMD Revolution Medicines, Inc.36,249$5.9M0.22%New
YARW Yarrow Bioscience, Inc.416,993$5.8M0.22%New
CAPR Capricor Therapeutics, Inc.699,149$5.6M0.21%Reduced −8%
SNDX Syndax Pharmaceuticals, Inc.615,990$5.5M0.21%Reduced −62%
BDSX Biodesix, Inc.667,835$5.3M0.20%Added +14%
TWST Twist Bioscience Corporation47,532$5.0M0.19%Reduced −55%
CSTL Castle Biosciences, Inc.141,137$4.6M0.18%New
IOVA Iovance Biotherapeutics, Inc.551,977$3.9M0.15%Added +268%
IVVD Invivyd, Inc.7,524,958$3.4M0.13%Reduced −2%
AVTX Avalo Therapeutics, Inc.383,594$2.6M<0.1%Reduced −77%
SLDB Solid Biosciences Inc.368,123$2.3M<0.1%Added +145%
ETRA Electra Therapeutics, Inc.250,000$2.1M<0.1%New
MSLE Satellos Bioscience Inc.330,102$1.9M<0.1%Added +5%
SABS SAB Biotherapeutics, Inc.672,039$1.8M<0.1%Reduced −25%
TNDM Tandem Diabetes Care, Inc.100,000$1.8M<0.1%Reduced −83%
WAY Waystar Holding Corp.50,000$1.3M<0.1%New
CNTX Context Therapeutics Inc.7,063,141$1.2M<0.1%Unchanged
MNKD MannKind Corporation300,100$1.2M<0.1%New
ZNTL Zentalis Pharmaceuticals, Inc.706,280$982K<0.1%Reduced −26%
CERS Cerus Corporation450,000$853K<0.1%Reduced −82%
NXTC NextCure, Inc.90,000$599K<0.1%New
NSPR InspireMD, Inc.1,045,708$594K<0.1%Unchanged
SUPN Supernus, Inc.10,000$291K<0.1%Reduced −99%
APRE Aprea Therapeutics, Inc.1,000,000$270K<0.1%New
PCSA Processa Pharmaceuticals, Inc.160,943$243K<0.1%New
UNH UnitedHealth Group Incorporated660$228K<0.1%Reduced −99%
BNTX BioNTech SE2,500$202K<0.1%New
BLTE Belite Bio, Inc1,524$199K<0.1%Reduced −97%
VIR Vir Biotechnology, Inc.20,971$181K<0.1%Reduced −98%
QDEL QuidelOrtho Corporation20,000$170K<0.1%New
ATTO Attovia Therapeutics, Inc.10,000$151K<0.1%New
EQ Equillium, Inc.90,000$103K<0.1%Unchanged
RXST RxSight, Inc.20,000$91K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
GMED Globus Medical, Inc.468,922$31.7M
SYRE Spyre Therapeutics, Inc.147,000$14.0M
IMVT Immunovant, Inc.252,000$8.1M
ELVN Enliven Therapeutics, Inc.165,677$7.7M
MIRM Mirum Pharmaceuticals, Inc.75,000$7.3M
AORT Artivion, Inc.388,000$7.2M
MRK Merck & Co., Inc.50,000$6.8M
ALNY Alnylam Pharmaceuticals, Inc.33,050$5.0M
NKTR Nektar Therapeutics128,362$4.0M
IMUX Immunic, Inc.450,000$3.2M
RLMD Relmada Therapeutics, Inc.842,106$2.4M
TECX Tectonic Therapeutic, Inc.101,684$2.1M
GPCR Structure Therapeutics Inc.107,000$1.8M
CORT Corcept Therapeutics Incorporated19,653$1.3M
VCYT Veracyte, Inc.25,000$623K
LRMR Larimar Therapeutics, Inc.188,102$567K
AVBP ArriVent BioPharma, Inc.50,000$549K
SION Sionna Therapeutics, Inc.177,687$510K
WGS GeneDx Holdings Corp.10,000$471K
CGEM Cullinan Therapeutics, Inc.50,000$450K
CGON CG Oncology, Inc.5,000$409K
NTRA Natera, Inc.1,000$277K
QNRX Quoin Pharmaceuticals, Ltd.72,730$253K
NEO NeoGenomics, Inc.10,000$149K
KPTIQ Karyopharm Therapeutics Inc.440,000$15K